AI assistant
MEDIFAST INC — Director's Dealing 2022
Feb 24, 2022
33899_dirs_2022-02-24_333ed883-14fd-44fc-a134-d4197d1b52b9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2022-02-22
Reporting Person: Chard Daniel R (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-22 | Common Stock | F | 1804 | $177.06 | Disposed | 13912 | Direct |
| 2022-02-22 | Common Stock | F | 1282 | $177.06 | Disposed | 12630 | Direct |
Footnotes
F1: These shares vested on February 19, 2022, which fell on a weekend. The settlement date of this vesting and subsequent withholding fell on the following business day, February 22, 2022.
F2: Pursuant to the terms of the Issuer's Amended and Restated 2012 Share Incentive Plan, the price was the closing sales price for the most recent trading day prior to the vesting date.
F3: These shares vested on February 20, 2022, which fell on a weekend. The settlement date of this vesting and subsequent withholding fell on the following business day, February 22, 2022.